Company / Operating Cash Flow
Biohaven Ltd. Operating Cash Flow History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$582.5M
FY2024
5-year range
-$582.5M / -$76.0M
FY2020-FY2024
Trend
-75.6%
vs FY2023
Sector context
#210 of 216
Health Care
What the data says
Among 216 Health Care companies, Biohaven Ltd. is in the bottom 3% for operating cash flow. Operating Cash Flow has declined for 4 consecutive years, from -$76M in FY2020 to -$582M in FY2024.
Based on SEC 10-K filings.
-$582M in FY2024.
Declined from -$298M to -$582M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 3% in Health CareTop 97% of 216This company -$582.5M Sector average $659.0M
▼
-188.4% below sector average
Key checks
Key Insights
- Biohaven Ltd.'s operating cash flow has declined for 4 consecutive years.
- In FY2024, operating cash flow decreased 75.6% year-over-year.
- Ranks #210 out of 216 companies in the Health Care sector.
- Peak operating cash flow was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$582.5M | -75.6% |
| FY2023 | -$331.7M | -11.4% |
| FY2022 | -$297.7M | -104.1% |
| FY2021 | -$145.8M | -92.0% |
| FY2020 | -$76.0M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026